Twin Securities Lowered Alere (Call) (ALR) Holding by $15.06 Million as Share Value Rose; First Fiduciary Investment Counsel Decreased Holding in Johnson & Johnson (JNJ) by $5.99 Million

November 15, 2017 - By Linda Rogers

Twin Securities Inc decreased its stake in Alere Inc (Call) (ALR) by 75.54% based on its latest 2017Q2 regulatory filing with the SEC. Twin Securities Inc sold 301,100 shares as the company’s stock rose 18.05% with the market. The hedge fund held 97,500 shares of the in vitro & in vivo diagnostic substances company at the end of 2017Q2, valued at $4.89M, down from 398,600 at the end of the previous reported quarter. Twin Securities Inc who had been investing in Alere Inc (Call) for a number of months, seems to be less bullish one the $4.47B market cap company. It closed at $50.99 lastly. It is down 17.58% since November 15, 2016 and is uptrending. It has outperformed by 0.88% the S&P500.

First Fiduciary Investment Counsel Inc decreased its stake in Johnson & Johnson (JNJ) by 24.45% based on its latest 2017Q2 regulatory filing with the SEC. First Fiduciary Investment Counsel Inc sold 45,377 shares as the company’s stock rose 6.85% with the market. The institutional investor held 140,236 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $18.55M, down from 185,613 at the end of the previous reported quarter. First Fiduciary Investment Counsel Inc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $374.74B market cap company. The stock decreased 0.20% or $0.28 during the last trading session, reaching $139.49. About 834 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since November 15, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.




Investors sentiment increased to 1.01 in 2017 Q2. Its up 0.23, from 0.78 in 2017Q1. It increased, as 47 investors sold ALR shares while 54 reduced holdings. 46 funds opened positions while 56 raised stakes. 72.72 million shares or 3.12% less from 75.06 million shares in 2017Q1 were reported. Hightower Ltd Liability Co owns 31,738 shares for 0.01% of their portfolio. 52,815 were reported by Legal And General Group Incorporated Public Ltd Liability Corp. Moreover, Baystate Wealth Mgmt Limited Liability Corp has 0% invested in Alere Inc (NYSE:ALR). Tig Advsr Limited Liability Company has invested 7.99% in Alere Inc (NYSE:ALR). Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Alere Inc (NYSE:ALR). Credit Suisse Ag holds 0.03% of its portfolio in Alere Inc (NYSE:ALR) for 521,811 shares. Gamco Et Al has invested 0.16% in Alere Inc (NYSE:ALR). Bogle Inv Mngmt Lp De invested in 129,813 shares or 0.47% of the stock. Bnp Paribas Arbitrage Sa reported 0% of its portfolio in Alere Inc (NYSE:ALR). Adage Cap Ltd Liability Corp, Massachusetts-based fund reported 550,000 shares. Natixis has invested 0.01% in Alere Inc (NYSE:ALR). Parametric Associates stated it has 0% of its portfolio in Alere Inc (NYSE:ALR). Ameriprise Financial has invested 0.01% in Alere Inc (NYSE:ALR). Redwood Cap Mngmt Limited accumulated 30,000 shares. Moreover, Vaughan Nelson Inv LP has 0.01% invested in Alere Inc (NYSE:ALR) for 14,825 shares.

Twin Securities Inc, which manages about $752.99M and $623.36 million US Long portfolio, upped its stake in Monsanto Co New (NYSE:MON) by 278,721 shares to 297,121 shares, valued at $35.17M in 2017Q2, according to the filing. It also increased its holding in Mobileye N V Amstelveen (NYSE:MBLY) by 1.17M shares in the quarter, for a total of 1.42 million shares, and has risen its stake in Nxp Semiconductors N V (Call) (NASDAQ:NXPI).

More notable recent Alere Inc (NYSE:ALR) news were published by: Sun-Sentinel.com which released: “Diabetes supply companies closing, laying off 182 workers” on November 02, 2017, also Nasdaq.com with their article: “Prem Watsa Buys Alere Inc, Chicago Bridge & Iron Co NV, Cray Inc, Sells …” published on November 15, 2017, Gurufocus.com published: “Css Llc Buys Altaba Inc, Alere Inc, Black Hills Corp, Sells Dominion Energy …” on November 15, 2017. More interesting news about Alere Inc (NYSE:ALR) were released by: Streetinsider.com and their article: “Form S-8 POS ALERE INC.” published on November 03, 2017 as well as Gurufocus.com‘s news article titled: “Prem Watsa Buys Alere Inc, Chicago Bridge & Iron Co NV, Cray Inc, Sells …” with publication date: November 14, 2017.

Among 7 analysts covering Alere (NYSE:ALR), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. Alere had 21 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, August 4 by BTIG Research. The firm has “Neutral” rating given on Tuesday, March 15 by BTIG Research. Leerink Swann upgraded the stock to “Outperform” rating in Thursday, April 28 report. The firm has “Hold” rating by Craig Hallum given on Monday, May 15. On Thursday, June 1 the stock rating was maintained by Jefferies with “Hold”. The firm has “Hold” rating by Canaccord Genuity given on Tuesday, September 19. On Tuesday, May 23 the stock rating was maintained by Canaccord Genuity with “Buy”. Craig Hallum upgraded the stock to “Buy” rating in Friday, April 29 report. Canaccord Genuity downgraded the shares of ALR in report on Tuesday, February 2 to “Hold” rating. BTIG Research maintained the shares of ALR in report on Thursday, May 25 with “Hold” rating.

First Fiduciary Investment Counsel Inc, which manages about $469.31M and $522.73 million US Long portfolio, upped its stake in Johnson Controls Int’l by 11,953 shares to 330,097 shares, valued at $14.31M in 2017Q2, according to the filing. It also increased its holding in Intel Corp (NASDAQ:INTC) by 174,485 shares in the quarter, for a total of 634,658 shares, and has risen its stake in Bank Of Ny Mellon (NYSE:BK).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 13 have Buy rating, 5 Sell and 5 Hold. Therefore 57% are positive. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Outperform” rating by Cowen & Co on Tuesday, August 25. The company was maintained on Wednesday, October 18 by Morgan Stanley. The firm has “Buy” rating given on Wednesday, October 14 by S&P Research. The stock of Johnson & Johnson (NYSE:JNJ) has “Neutral” rating given on Friday, December 18 by Atlantic Securities. The firm has “Equal-Weight” rating given on Tuesday, November 29 by Barclays Capital. The company was upgraded on Wednesday, July 20 by Argus Research. Jefferies maintained Johnson & Johnson (NYSE:JNJ) on Tuesday, June 14 with “Hold” rating. As per Tuesday, June 13, the company rating was maintained by Cowen & Co. The firm earned “Outperform” rating on Wednesday, October 7 by RBC Capital Markets. Jefferies maintained the stock with “Hold” rating in Tuesday, September 13 report.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 earnings per share, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62 billion for 20.27 P/E if the $1.72 EPS becomes a reality. After $1.90 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.